Just In
- 6 hrs ago Aditi Rao Hydari Marries Siddharth, Exploring Heeramandi Star's Ethnic Style Statements, Bookmark Now!
- 8 hrs ago Solar Eclipse 2024 Date And Time: Will It Be Visible In India? When And Where To Watch It, Deets Inside!
- 10 hrs ago Balenciaga Tape Bracelet: Is It Worth Spending A Bomb On Adhesive Looking Accessory? Know Our Take!
- 12 hrs ago In China, GenZ Workers Are Ditching Formal Attire For Pyjamas, Know The Reason Behind This
Don't Miss
- Sports RR vs DC: Top Memes As Ashwin Hammers Steaming Anrich Nortje For Two Massive Sixes - 'He Can Filter Air in Delhi'
- News More to Pay? Bengaluru-Mysuru Expressway Toll Fee Rise Again: New Rates Effective April 1st
- Movies Emraan Hashmi Shares First Look From OG, To Play Omi Bhau In Next Project After Showtime & Ae Watan Mere Watan
- Finance 45% Dividend: Maharatna Powerpack NBFC REC Turned Ex-Dividend; To Raise Rs 1,60,000 Crore Soon; BUY More?
- Automobiles Xiaomi SU7 Electric Car Launched – May End Apple Inc.
- Technology HONOR Pad 9 With Bluetooth Keyboard Up For Grabs At Rs 22,499 in India
- Education RSMSSB Junior Instructor Recruitment 2024; Apply online for 2500 Posts, Check out for more details
- Travel Explore Tamil Nadu's Diverse Wedding Venues
Bengaluru Scientists Have Found A New Painkiller For Chronic Or Neuropathic Pain
In a new study, two scientists at the Indian Institute of Science (IISc), Bengaluru have found a new painkiller for cancer patients or people who are amputated or undergone surgery who feel persistent and severe pain for weeks or months.
The study conducted by Saurabh Yadav and Avadhesha Surolia from IISc's Molecular Biophysics Unit examined how an enzyme that usually digests bacteria can promote chronic pain related to nerve injury. The study involved mice, rats and human postmortem tissues [1] .
The result of the study will help explain how injuries and inflammation in neurons can elevate pain sensitivity. It also suggests that the inhibitors of the enzyme could be a possible therapy for chronic or neuropathic pain.
Pain is divided into two groups - inflammatory and neuropathic or chronic pain, which is stimulated by damage to the central nervous system. The former one can be controlled with normal painkillers, but excepting opioids, there is no other option for doctors to tackle the second type of pain.
Neuropathic pain is caused by a damage or disease affecting the somatosensory nervous system. The current treatment options are ineffective against such pain.
According to Avadhesha Surolia, they identified lysozyme - a bacteria eating enzyme and an important part of the immune system as the main contributor to the development of neuropathic pain.
Both the scientists found two ways to disrupt lysozyme's functions in the body, leading to two potential drug targets. They will further find out which one of these two ways is better and if there are any side effects.
Apart from improving a person's health, a new painkiller would have a huge contribution to enhance economic productivity.
- [1] Yadav, S., & Surolia, A. (2019). Lysozyme elicits pain during nerve injury by neuronal Toll-like receptor 4 activation and has therapeutic potential in neuropathic pain.Science Translational Medicine,11(504), eaav4176.
- wellnessScientists Identify Link Between Calcium, Cholesterol
- healthDo You Take Painkillers For Every Single Pain? You May Be At Risk Of These Side Effects
- wellnessCOVID-19: List Of Drugs That May Fight Coronavirus Symptoms
- disorders cureAntibiotic-resistant Infections On The Rise, Reveals New Study
- healthMalaria Parasites Become Resistant To Anti-malaria Drugs: Result Failure In Treatment
- wellnessWhat You Should Know About Opioid Epidemic?
- wellnessWhat Is Polypharmacy? What Are Its Side Effects?
- wellness7 Ways To Combat Weight Gain Due To Medication
- wellnessThese Ayurvedic Medicines Are Not Safe For Your Kids!
- wellness11 Commonly Prescribed Medicines Have Highest Depression Risk
- wellness9 Surprising Reasons For Frequent Urination
- wellnessTop Powerful Antibiotics That Help Ditch Prescribed Medicines